Concurrently, BHLHE41 modulates cancer progression through competitive binding at promoter regions of EMT master regulators (Snail, Slug, and Twist), thereby facilitating EMT-driven breast cancer cell invasion and metastasis [58,59]. Here, SNAI2 is linked to breast carcinoma.